E-LIB Suche - Ergebnisse für: Sotelo-Rodríguez, Carolina - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Molecular Tumor Board Improves Outcomes for Hispanic Patien..:

Sotelo-Rodríguez, Carolina ; Vallejo-Ardila, Dora ; Ruiz-Patiño, Alejandro...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10805441/. , 2024

Link: http://www.ncbi.nlm.nih...

2

Molecular Tumor Board Improves Outcomes for Hispanic Patien..:

Carolina Sotelo-Rodríguez ; Dora Vallejo-Ardila ; Alejandro Ruiz-Patiño...
https://ascopubs.org/doi/10.1200/GO.23.00011. , 2024

Link: https://doi.org/10.1200/..

3

Antibiotics impair immune checkpoint inhibitor effectivenes..:

Ruiz-Patinõ, Alejandro ; Barrón-Barrón, Feliciano ; Cardona, Andres...
Thoracic cancer, 1759-7714, 2020. , 2020

Link: https://hdl.handle.net/2..

4

Application of Comprehensive Genomic Profiling-Based Next-G..:

Cifuentes, Claudia ; Lombana, Milton ; Vargas, Henry...
Cancer Control. 30 (2023) - p. , 2023

Link: https://doi.org/10.1177/..

5

PD.01.03 Genomic Landscape of Primary-Resistance to Osimert..:

Chamorro, Diego ; Cardona, Andres ; Rodriguez, July...
Journal of Thoracic Oncology. 18 (2023) 3 - p. S4 , 2023

Link: https://doi.org/10.1016/..

6

Genomic Landscape of Primary Resistance to Osimertinib Amon..:

Chamorro, Diego F. ; Cardona, Andrés F. ; Rodríguez, July...
Targeted Oncology. 18 (2023) 3 - p. 425-440 , 2023

Link: https://doi.org/10.1007/..

7

DICER1-associated central nervous system sarcoma: A compreh..:

Cardona, Andrés F ; Chamorro Ortiz, Diego Fernando ; Ruíz-Patiño, Alejandro...
Neuro-Oncology Practice. 10 (2023) 4 - p. 381-390 , 2023

Link: https://doi.org/10.1093/..

8

p.G12C KRAS mutation prevalence in non-small cell lung canc..:

Ruiz-Patiño, Alejandro ; Rodríguez, July ; Cardona, Andrés F....
Translational Oncology. 15 (2022) 1 - p. 101276 , 2022

Link: https://doi.org/10.1016/..

9

Mechanisms of Resistance to First-Line Osimertinib in Hispa..:

Cardona, Andrés F. ; Ruiz-Patiño, Alejandro ; Recondo, Gonzalo...
Clinical Lung Cancer. 23 (2022) 6 - p. 522-531 , 2022

Link: https://doi.org/10.1016/..

10

Efficacy of osimertinib plus bevacizumab in glioblastoma pa..:

Cardona, Andrés F. ; Jaramillo-Velásquez, Daniel ; Ruiz-Patiño, Alejandro...
Journal of Neuro-Oncology. 154 (2021) 3 - p. 353-364 , 2021

Link: https://doi.org/10.1007/..

11

Characteristics and outcomes of thymomas in Latin America: ..:

Martín, Claudio ; Enrico, Diego ; Mas, Luis...
Thoracic Cancer. 12 (2021) 9 - p. 1328-1335 , 2021

Link: https://doi.org/10.1111/..

12

Antibiotics impair immune checkpoint inhibitor effectivenes..:

Ruiz‐Patiño, Alejandro ; Barrón, Feliciano ; Cardona, Andrés F....
Thoracic Cancer. 11 (2020) 9 - p. 2552-2560 , 2020

Link: https://doi.org/10.1111/..

13

Immunotherapy at any line of treatment improves survival in..:

Ruiz‐Patiño, Alejandro ; Arrieta, Oscar ; Cardona, Andrés F....
Thoracic Cancer. 11 (2019) 2 - p. 353-361 , 2019

Link: https://doi.org/10.1111/..

14

Application of Comprehensive Genomic Profiling-Based Next-G..:

Claudia Cifuentes ; Milton Lombana ; Henry Vargas...
https://doi.org/10.1177/10732748231175256. , 2023

Link: https://doi.org/10.1177/..

15

Importancia pronóstica de las mutaciones del gen promotor d..:

Alejandro Cañas ; Enrique Jiménez ; Fernando Hakim...
https://revistabiomedica.org/index.php/biomedica/article/view/6100. , 2022

Link: https://doi.org/10.7705/..

1-15